Gille; Hendrik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gille; Hendrik.The latest application filed is for "novel proteins specific for angiogenesis".

Company Profile

3.7.12

Gille; Hendrik - Munich DE
Gille; Hendrik - Berlin DE
Gille; Hendrik - Muenchen DE
Gille, Hendrik - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2) Grant 11,034,738 - Bel Aiba , et al. June 15, 2	2021-06-15
Novel Proteins Specific For Angiogenesis App 20200140501 - Bel Aiba; Rachida Siham ; et al.	2020-05-07
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof Grant 10,526,382 - Bel Aiba , et al. J	2020-01-07
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20180311311 - Hohlbaum; Andreas ; et al.	2018-11-01
Methods and compositions for treating disorders Grant 10,064,963 - Olwill , et al. September 4, 2	2018-09-04
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Grant 9,950,034 - Hohlbaum , et al. April 24, 2	2018-04-24
Novel Proteins Specific For Angiogenesis App 20180016312 - BEL AIBA; Rachida Siham ; et al.	2018-01-18
Human Neutrophil Gelatinase-associated Lipocalin (hngal) Muteins That Bind Hepcidin And Nucleic Acid Encoding Such App 20170369542 - TRENTMANN; Stefan ; et al.	2017-12-28
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20170224770 - HOHLBAUM; ANDREAS ; et al.	2017-08-10
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Grant 9,610,356 - Hohlbaum , et al. April 4, 2	2017-04-04
Human Neutrophil Gelatinase-associated Lipocalin (hngal) Muteins That Bind Hepcidin And Nucleic Acid Encoding Such App 20150291675 - TRENTMANN; STEFAN ; et al.	2015-10-15
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such Grant 9,051,382 - Trentmann , et al. June 9, 2	2015-06-09
Methods For Preventing, Treating Or Diagnosing Disorders App 20150004098 - Olwill; Shane ; et al.	2015-01-01
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20140323389 - Hohlbaum; Andreas ; et al.	2014-10-30
Binding Proteins For Hepcidin App 20130244955 - Trentmann; Stefan ; et al.	2013-09-19
Controlled Release Formulations Of Lipocalin Muteins App 20120201873 - Hohlbaum; Andreas ; et al.	2012-08-09
Apoptosis-inducing dna sequences App 20040088746 - Grimm, Stefan ; et al.	2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.